Physician profile
Rafael Pelayo
NPI 1699822940
$15,473.05
in general payments reported to CMS, 2019-2025
4 companies · $3,628 in 2025
The $3,628 reported for 2025 was more than what 89% of Sleep Medicine (Pediatrics) providers received nationally (typical 2025 total: $235).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $124 · 2022: $5,499 · 2023: $6,079 · 2024: $143 · 2025: $3,628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,775 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,750 · Travel and Lodging: $903 · Food and Beverage: $422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,775.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,750.00 |
| Travel and Lodging | $902.92 |
| Food and Beverage | $422.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $6,552.29 | 2022-2023 | Quviviq |
| Eisai INC. | $5,047.95 | 2021-2022 | |
| Fisher & Paykel Healthcare INC | $3,627.87 | 2025 | Fisher & Paykel Healthcare |
| Jazz Pharmaceuticals INC. | $244.94 | 2023-2024 | Xywav |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafael Pelayo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.